Bacterial DNA and intracellular macromolecules

Bacterial DNA and intracellular macromolecules represent a broad category of essential cellular components that serve as the primary targets for several classes of antimicrobial agents, including nitroimidazoles and nitrofurans. Bacterial DNA is the repository of genetic information required for replication and protein synthesis, while intracellular macromolecules such as proteins and RNA are critical for enzymatic functions and structural integrity (StatPearls, NBK539728). Drugs like metronidazole act as prodrugs that are selectively reduced in anaerobic environments to form highly reactive nitroso-free radicals. These radicals cause extensive damage to the DNA helical structure, leading to strand breakage and the inhibition of nucleic acid synthesis (PubMed, 10.1128/AAC.01034-17). Similarly, nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates that attack ribosomal proteins and other macromolecules, disrupting multiple metabolic pathways (StatPearls, NBK470526). This multi-target mechanism is highly effective against anaerobic bacteria and certain protozoa, although it necessitates careful consideration of potential mutagenic effects and host toxicity. Because this target definition encompasses a wide array of distinct molecular entities rather than a single protein or receptor, it is often used to describe the broad-spectrum damage caused by reactive drug metabolites.

Other names

Bacterial nucleic acidsBacterial genomeBacterial cellular componentsBacterial macromolecules

Reduction of the drug to reactive radical intermediates that cause oxidative damage, DNA strand breakage, and covalent modification of proteins and other cellular macromolecules.